Qyuns Therapeutics – Talk Bio

Actionable Insights Powered by AI

Caldera Therapeutics Launches with $112.5M Funding for China-Licensed IBD Bispecific Antibody

2 weeks ago talkbio0Tagged Antibodies, Bispecific, Caldera Therapeutics, CLD-423, Funding, Inflammatory Bowel Diseases, Qyuns Therapeutics

Caldera Therapeutics; IBD; bispecific antibody; $112.5M funding; Qyuns Therapeutics; CLD-423

Roche Signs $1B Licensing Deal with Qyuns Therapeutics for Preclinical COPD Bispecific Antibody

3 months ago talkbio0Tagged Antibodies, Bispecific, biobucks, China, COPD, IL33 protein, human, Preclinical, Qyuns Therapeutics, Respiration Disorders, Roche (company), TSLP gene

Roche; Qyuns Therapeutics; bispecific antibody; COPD; preclinical; TSLP; IL-33; China biotech; biobucks; respiratory disease